Can iBio (IBIO) reach $30 in the next year?
What’s up with iBio?
iBio (IBIO) opened at $0.97, which means the stock is down 1.00% from yesterday’s closing price of 1.01. Today, the company has a high of $1.01 and a low of $0.96. The company has a market cap of $102.46 million with a 52-week high of $3.40 and a 52-week low of $0.05.
What about the future for iBio?
The high forecast for iBio is 30.00 while the low is 9.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. iBio has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future. Based on this information IBIO seems to be a safe buy.
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.